Abstract
Staphylococcus intermedius is a rare cause of human infections ranging from skin and soft tissue infections to bacteremia. It is particularly known for its association with exposure to dogs. We report an unusual case of a 73-year-old female with a brain abscess caused by S intermedius who was recently diagnosed with hereditary hemorrhagic telangiectasia and a pulmonary arteriovenous malformation. The patient underwent debridement of the brain abscess followed by a 6-week course of vancomycin and rifampin, after which she made a near complete recovery. This is the first case of a brain abscess in an adult due to S intermedius in the published literature, and we provide a comprehensive review of the literature of all human infections caused by this pathogen and summarize its clinical manifestations, treatment recommendations, and outcomes.
Keywords: abscess, HHT, PAVM, Staphylococcus
Staphylococcus intermedius is an unusual pathogen in humans. Infection is often associated with animal contact and is considered a “zoonotic organism” found as part of the oral and skin flora of dogs, pigeons, foxes, minks, and horses [1]. Staphylococcus intermedius uncommonly may cause human infections ranging from skin and soft tissue infections (SSTIs) to bacteremia [2].
In this study, we aim to enhance the recognition of this increasingly important human pathogen by presenting an unusual case of a brain abscess due to S intermedius and providing a comprehensive review of the published English literature summarizing human infections due to this pathogen. Our report also highlights pulmonary arteriovenous malformation (PAVM) as a risk factor for developing unusual infections including brain abscesses.
CASE REPORT
A 73-year-old female with prediabetes, congestive heart failure, and recently diagnosed hereditary hemorrhagic telangiectasia (HHT) presented with sudden onset of right-sided lower facial droop, numbness, and slurred speech. Physical examination showed visible telangiectasias on her tongue (Figure 1). Computed tomography (CT) of the brain without contrast revealed a nonspecific low-density lesion of the left posterior frontal lobe cortex. To further evaluate this abnormality, a magnetic resonance imaging (MRI) was performed and demonstrated a 1.2-cm intracerebral ring-enhancing lesion consistent with an abscess in the posterior left frontal lobe (Figure 2). The lesion was too small for stereotactic biopsy.
Figure 1.
Telangiectasias on tongue as a manifestation of her underlying hereditary hemorrhagic telangiectasia.
Figure 2.
Magnetic resonance imaging of the brain demonstrated a ring-enhancing lesion consistent with a brain abscess in the posterior left frontal lobe with surrounding vasogenic edema.
Blood cultures showed no growth, and CT of the chest, abdomen, and pelvis were notable for a large 5.9-cm left lower lobe PAVM and believed to be related to her underlying HHT (Figure 3). A CT angiography of the head and neck with contrast did not show intracerebral arteriovenous malformation. The patient was empirically treated for the brain abscess with intravenous vancomycin and ceftriaxone as well as oral metronidazole for a planned 6-week course.
Figure 3.
Chest computed tomography showing an enhancing 5.9-cm mass in the left lower lobe that has a feeding branch from the left lower lobe pulmonary artery and a large draining vein that communicates with the left inferior pulmonary vein. Findings are consistent with a large pulmonary arteriovenous malformation.
The patient was re-admitted for vomiting thought to be associated with the antibiotics, specifically the metronidazole. Repeat MRI of the brain, 20 days after initial imaging, showed an increase in the size of the brain abscess, with worsening vasogenic edema. The patient underwent left frontal craniotomy with excision of the brain abscess. Operative findings showed an abscess with a thick capsule with purulent material. Intraoperative bacterial, fungal, and acid-fast bacillus cultures were negative. Broad-range polymerase chain reaction (PCR) performed at the University of Washington was positive for S intermedius without other identified organisms. Upon further questioning, the patient reported that she was a dog owner. Because no susceptibilities were available given negative culture results, we proceeded with intravenous vancomycin and oral rifampin for 6 weeks based on the available literature.
Due to suspected systemic embolism from the large PAVM and perceived high risk for surgical therapy, she was referred to interventional cardiology for closure of the PAVM. Pulmonary angiography demonstrated a 9-mm patulous pulmonary artery branch to the 5.9-cm AVM sac. The PAVM feeder artery underwent successful obliteration using a 14-mm St. Jude Amplatzer AVP2 vascular plug without compromise to adjacent healthy lung tissue. She was treated with baby aspirin and underwent serial surveillance CT imaging that showed a decrease in the size of the AVM. On follow-up, she had experienced no other neurologic or infectious complications and only had mild persistent facial numbness.
Patient Consent Statement
The patient could not be reached through the contact information provided in her chart to obtain signed authorization to publish the case report. Before drafting the case report, the medical information was stripped off all 18 Health Insurance Portability and Accountability Act (HIPAA) identifiers. In addition, the re-identification is unlikely because no identifying characteristics of the patient are connected to the case and the patient was not aware of the uniqueness of her case. Hence according to 45 CFR 164.514(b), the information is no longer protected health information (PHI) and written authorization is not required for publication of the case report. Of note, Figure 1 was obtained through the hospital’s secure photo upload mechanism of Epic Haiku and cannot be used to identify the patient.
REVIEW OF THE LITERATURE
We searched the English literature from January 1975 to September 2019 through PubMed and Google Scholar using the search terms, “Staphylococcus intermedius” and “S. intermedius.” Only human infections were included. Articles were excluded if the culprit bacterium was “Streptococcus intermedius” or “Staphylococcus pseudointermedius”; or if the article was not in English. The citations of these articles were also examined for additional cases. This yielded a total of 21 articles that included 42 total cases, including this report (Table 1) [2–22].
Table 1.
Cases of Infections Due to Staphylococcus intermedius Reported in the Literature
| Author, Year | Age, Sex | Presentation | Infection Site | Risk Factors | Pet Exposure | Treatment | Recovery |
|---|---|---|---|---|---|---|---|
| Talan, 1989 | 20, M | Hand, forearm, thigh wounds | Left thumb pain with movement | None | Dog bite | Penicillin V QID for 5 days | Full |
| Talan, 1989 | 34, F | Forearm wound | Forearm bite and pain | None | Dog bite | Penicillin V QID for 5 days | Full |
| Barnham, 1992 | 38, F | Hand wound | Pain, discharging wound | None | Dog bite | Amoxicillin-clavulanate | Full |
| Lee, 1994 | NR | NR | NR | NR | Dog bite | NR | NR |
| Lee, 1994 | NR | NR | NR | NR | Dog bite | NR | NR |
| Lee, 1994 | NR | NR | NR | NR | Dog bite | NR | NR |
| Lee, 1994 | NR | NR | NR | NR | Dog bite | NR | NR |
| Lee, 1994 | NR | NR | NR | NR | Dog bite | NR | NR |
| Lee, 1994 | NR | NR | NR | NR | Dog bite | NR | NR |
| Lee, 1994 | NR | Leg Ulcer | NR | Varicose ulcer | Dog owner | NR | NR |
| Lee, 1994 | NR | Leg Ulcer | NR | Varicose ulcer | Dog owner | NR | NR |
| Lee, 1994 | 13, NR | Infected suture line | NR | NR | Dog contact | NR | NR |
| Vandenesch, 1995 | 63, M | Catheter-associated bacteremia | Fever | Metastatic NSC lung carcinoma, chemotherapy, splenectomy | Cat owner | Amoxicillin-clavulanate TID, ciprofloxacin BID for 10 days | Full |
| Gerstadt, 1999 | 73, M | Pneumonia | Fever and secretions | NIDDM, coronary arterial bypass graft | None | Vancomycin | Full |
| Talan, 1999 | NR | Wound | NR | NR | Dog bite | NR | NR |
| Talan, 1999 | NR | Wound | NR | NR | Cat bite | NR | NR |
| Tanner, 2000 | 38, F | Otitis Externa | NR | NR | Dog owner | Topical neomycin, polymyxin B | Full |
| Kikuchi, 2004 | 51, F | Mastoiditis | Irritation and otorrhea of the right ear | Tympanoplasty, radial mastoidectomy | Dog lick | Ofloxacin ear drops | Full |
| Pottumarthy, 2004 | 60, F | Nail bed Infection | Inflamed nail bed | Breast cancer, chemotherapy | NR | NR | NR |
| Pottumarthy, 2004 | 37, M | Cellulitis | Left leg cellulitis | NR | NR | NR | NR |
| Atalay, 2005 | 4, M | Brain abscess | Headache, fever, nausea, vomiting, right hemiparesis | None | NR | Vancomycin for 8 weeks | Minimal residual hemiparesis |
| Kempker, 2009 | 28, F | Sinusitis | Foul smelling nasal discharge and mild headache | Diabetes insipidus, pituitary adenoma status post transphenoidal resection 8 months prior, CSF leak | Dog owner and licked by dog with recent Staphylococcus intermedius pyoderma | Bilateral sphenoidotomy, vancomycin then linezolid for total 6 weeks | Full |
| Chuang, 2010 | 6, M | Catheter-associated bacteremia | Intermittent high fever | Hemophilia B | Dog owner | Vancomycin then oxacillin for 18 days | Full |
| Durdik, 2010 | 0, M | Meningitis | Persistent fever | None | Dog owner | Cefotaxime | Full |
| Kelesidis, 2010 | 43, M | Forearm abscesses | Chills after injecting intravenous cocaine | IVDA | None | Amoxicillin-clavulanate for 2 weeks | Full |
| Hatch, 2011 | 76, M | Bacteremia, septic arthritis, iliacus abscess | Generalized rash | DM | Dog owner | Vancomycin for 52 days | NR |
| Wang, 2013 | 73, F | Elbow wound | Fever, pain, swelling of left elbow | Recent left elbow total arthroplasty | Dog owner | Cefazolin daily then rifampin for 4 weeks | Full |
| Choi, 2014 | 32, F | Cervical necrotizing fasciitis | Severe chin discharge | 1 week postacupuncture | None | Sulbactam-ampicillin; ceftriaxone | Full |
| Koci, 2015 | 58, M | Pacemaker lead infection | Fever, chills, headache | Implanted pacemaker | Neighbor’s dog licked hand wound | Daptomycin then cefazolin | Full |
| Viau, 2015 | 78, M | Hallux osteomyelitis | Blood-filled blisters on his left foot | DM, prior foot burn | None | Doxycycline then vancomycin | Full |
| Viau, 2015 | 74, M | Hand cellulitis | Pain and clear exudate on the left hand | CHF | NR | Topical silver sulfadiazine | Lost to follow-up |
| Viau, 2015 | 77, M | Pacemaker site infection | Purulent drainage from pacemaker site | DM, cirrhosis, CHF | NR | “Antibiotics” | Full |
| Viau, 2015 | 59, M | Foot cellulitis | Foot cellulitis and fever | DM, chronic foot ulcer | Dog owner | Ceftriaxone for 4 weeks | Full |
| Viau, 2015 | NR | Foot osteomyelitis | NR | NR | NR | Toe amputation then (cefazolin or amoxicillin/clavulanic acid) | NR |
| Viau, 2015 | NR | Foot osteomyelitis | NR | NR | NR | Toe amputation then (cefazolin or amoxicillin/clavulanic acid) | NR |
| Viau, 2015 | NR | Foot osteomyelitis | NR | NR | NR | Toe amputation then (cefazolin or amoxicillin/clavulanic acid) | NR |
| Viau, 2015 | NR | Foot osteomyelitis | NR | NR | NR | Debridement then vancomycin for 6 weeks | NR |
| Viau, 2015 | NR | Foot infection | NR | NR | NR | Vancomycin | NR |
| Viau, 2015 | NR | Foot infection | NR | NR | NR | Bedside debridements then topical neomycin-polymyxin | NR |
| Lainhart, 2018 | 46, M | Toe ulceration | Left toe ulceration | IDDM, CHF, CAD, HTN | Dog owner | Doxycycline and gentamicin topical | Full |
| This Report, 2019 | 73, F | Brain abscess | Right-sided facial droop and slurred speech | Hereditary hemorrhagic telangiectasia, pulmonary AVM, CHF | Dog owner | Vancomycin and rifampin for 6 weeks | Mild residual paresthesia |
Abbreviations; AVM, arteriovenous malformation; BID, twice daily; CAD, coronary artery disease; CHF, congestive heart failure; CSF, cerebrospinal fluid; DM, diabetes mellitus; HTN, hypertension; IDDM, insulin-dependent diabetes mellitus; IVDA, intravenous drug abuse; NIDDM, noninsulin-dependent diabetes mellitus; NR, not reported; NSC, non-small cell; TID, thrice daily; QID, four times daily.
In terms of demographics, of those with reported data the average age was 46 years (±24), ranging from 11 months [3] to 78 years old [4]. The identified infections were more likely male with a 2:1 predominance (64% male, 36% female).
The majority (36 of 42) of the case presentations reported the type of infection and were predominantly SSTIs (25 cases, 69.4%). The remainder were device-associated infections (4 cases, 11.1%) [4–7]; bacteremia (3 cases, 8.3%) [5, 7, 8]; central nervous system ([CNS] 3 cases, 8.3%) (3, 9, this report); sinusitis or mastoiditis (2 cases, 5.6%) [9, 10]; bone or joint infection (2 cases, 5.6% [4, 8]; and pneumonia (1 case, 2.8%) [11]. One case of a pediatric brain abscess caused by S intermedius had been previously reported [12].
Given the presence of S intermedius as part of animal flora, cases were analyzed regarding animal exposure and the majority of patients reported exposure. Twenty-seven of 33 cases (75.8%) reported exposure to dogs and an additional 2 cases (7.4%) acknowledged exposure to cats.
Twenty-five (59.5%) cases reported an underlying medical condition. Of these cases, 6 (24.0%) reported diabetes mellitus and 4 (9.5%) cases reported congestive heart failure. The current case is unique given the underlying history of HHT and PAVM. Four cases noted an association with devices, including 2 with pacemaker lead infections [6], 1 from a pacemaker site infection [4], and 1 catheter-associated bacteremia [7]. An additional 4 cases (16.0%) noted overlying soft tissue damage in the area where the S intermedius infection emerged, including 2 patients with varicose ulcers [13], 1 patient with chronic foot ulcer, and 1 patient with a prior foot burn [4] (Table 1). One additional patient had recent acupuncture [14].
With regards to treatment, 25 cases (60.5%) provided the specific antibiotics used. Glycopeptides, namely vancomycin, were the most widely chosen among 10 cases (34.0%) using this class, with the vast majority (9 of 10 cases) electing vancomycin versus daptomycin. Penicillins were the second most chosen class of antibiotics with 7 cases (28.0%) and included uses of amoxicillin-clavulanic acid, penicillin, and ampicillin-sulbactam. Cephalosporins were used in 5 cases (20.0%), including 2 cases each (40.0%) of cefazolin and ceftriaxone, and 1 case (20%) using cefotaxime. Rifampin was used as combination therapy in 2 cases (7.7%). Single uses (4.0% each) were also noted for ciprofloxacin, gentamicin, linezolid, neomycin-polymyxin, ofloxacin, and sulfadiazine.
In terms of susceptibilities, 18 cases (42.3%) provided these data, and the most common reported susceptibility was to vancomycin (9 cases of 10 isolates tested, 90%), and gentamicin and erythromycin each with 7 reports (each with 8 isolates tested, 88%). Rifampin was susceptible in all 3 cases in which testing was performed. Penicillin had the poorest susceptibility (6 cases of 11 isolates tested, 55%). Additional susceptibilities are noted in Table 2.
Table 2.
Reported Antibiotic Susceptibilities
| Antibiotic Class | Number of Isolates Susceptible | Number of Isolates Tested |
|---|---|---|
| Macrolides | ||
| Erythromycin | 7 | 8 |
| Aminoglycosides | ||
| Gentamicin | 7 | 8 |
| Kanamycin | 1 | 1 |
| Cephalosporins | ||
| Cefazolin | 5 | 7 |
| Cefoxitin | 1 | 1 |
| Glycopeptides | ||
| Vancomycin | 9 | 10 |
| Lincosamides | ||
| Clindamycin | 6 | 8 |
| Lincomycin | 1 | 1 |
| Penicillins | ||
| Ampicillin-sulbactam | 3 | 4 |
| Oxacillin | 10 | 14 |
| Penicillin | 6 | 11 |
| Quinolones | ||
| Ciprofloxacin | 2 | 3 |
| Levofloxacin | 5 | 6 |
| Pefloxacin | 1 | 1 |
| Rifamycins | ||
| Rifampin | 3 | 3 |
| Streptogramins | ||
| Pristinamycin | 1 | 1 |
| Tetracyclines | ||
| Doxycycline | 2 | 3 |
Patients had excellent treatment outcomes. Of the 22 cases (52.4%) that reported outcomes, 19 (86.4%) stated that the patient had a full recovery. However, 2 of the 3 CNS cases (9.1%) noted residual neurologic deficits including residual hemiparesis [12] and facial numbness (current report).
DISCUSSION
Staphylococcus intermedius was initially isolated in 1976 from isolates originating from animals including dogs [1]. Initially, it was grouped with Staphylococcus aureus because it produced coagulase, DNases, and had similar growth patterns [23]. Staphylococcus intermedius was subsequently separated from S aureus when its cell wall composition and guanine-cytosine content were analyzed, ultimately being divided into 3 species: S intermedius, S pseudointermedius, and Staphylococcus delphini [15]. The identification of S intermedius serves as a challenge because it is often misidentified as S aureus due to its positivity on coagulase testing and its potential pathogenicity. In addition, S intermedius has been falsely identified as methicillin-resistant S aureus using phenotypic penicillin binding protein 2a (PBP2a) latex agglutination tests [24]. Fortunately, S intermedius can be confirmed through additional biochemical tests [1]. For example, in contrast to S aureus, S intermedius is pyrrolidonyl arylamidase and β-galactosidase positive [3]. Broad-range PCR is also a useful test to identify S intermedius especially when there is a small specimen obtained or in the presence of prior antibiotic use, and this technology can differentiate this organism from both S aureus and S pseduointermedius. Of note, given the aforementioned difficulties in identifying this organism, it is likely that human infection cases with S intermedius have been underestimated.
An increasing body of literature has implicated an association between HHT, PAVM, and increased rates of infection, in particular cerebral infections that may involve atypical pathogens [25]. The increased risk of infection stems from the direct connection between the pulmonary and systemic circulation circumventing the capillary beds, increasing the ability for bacteria to translocate and disseminate to distant sites including the brain [25]. There are increased rates of cerebral abscesses in patients with similar right to left shunting including patent foramen ovale and congenital cyanotic cardiopathy [16]. Of note, many patients who present with cerebral abscesses, including our case, were asymptomatic from the PAVM before presentation [26]. Screening methods for pulmonary AVMs include detection of right-to-left shunt by radionucleotide perfusion scan or contrast echocardiography. Transcatheter embolectomy is the current standard treatment for PAVMs [27] and is important for limiting future neurologic and infectious complications. We believe the patient’s PAVM predisposed her to this unusual infection in the setting of exposure to her dog.
CONCLUSIONS
To the best of our knowledge, this is the first reported case of a brain abscess stemming from S intermedius in an adult and second report overall. Fortunately, this infection, including this case, is often susceptible to antibiotics such as the vancomycin and rifampin, which we chose. Exposure to dogs remains the most consistent and preventable risk factor, with our patient’s PAVM serving as a conduit for this infection to reach her brain. It is fortunate that cases such as these represent a minority of exposures to dogs; avoidance of these common pets cannot be realistically recommended, but a history of exposure serves as a clue to the possibility of zoonotic organisms such as S intermedius. Furthermore, PAVMs can be a further risk factor for atypical infections in unusual locations.
Acknowledgments
Author contributions. All 4 authors contributed to the content and authorship of this manuscript.
Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
References
- 1. Hajek V. Staphylococcus intermedius, a new species isolated from animals. Int J Syst Bacteriol 1976; 26:401–8. [Google Scholar]
- 2. Wang N, Neilan AM, Klompas M. Staphylococcus intermedius infections: case report and literature review. Infect Dis Rep 2013; 5:e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Durdik P, Fedor M, Jesenak M, et al. Staphylococcus Intermedius—rare pathogen of acute meningitis. Int J Infect Dis 2010; 14S:e236–8. [DOI] [PubMed] [Google Scholar]
- 4. Viau R, Hujer AM, Hujer KM, et al. Are staphylococcus intermedius infections in humans cases of mistaken identity? A case series and literature review. Open Forum Infect Dis 2015; 2:ofv110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Chuang CY, Yang YL, Hsueh PR, Lee PI. Catheter-related bacteremia caused by Staphylococcus pseudintermedius refractory to antibiotic-lock therapy in a hemophilic child with dog exposure. J Clin Microbiol 2010; 48:1497–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Koci F, Sekar A, Pacifico L, Esposito A. A canine bug in a human heart. QJM 2015; 108:337–8. [DOI] [PubMed] [Google Scholar]
- 7. Vandenesch F, Célard M, Arpin D, et al. Catheter-related bacteremia associated with coagulase-positive Staphylococcus intermedius. J Clin Microbiol 1995; 33:2508–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Hatch S, Sree A, Tirrell S, et al. Metastatic complications from Staphylococcus intermedius, a zoonotic pathogen. J Clin Microbiol 2012; 50:1099–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kempker R, Mangalat D, Kongphet-Tran T, Eaton M. Beware of the pet dog: a case of Staphylococcus intermedius infection. Am J Med Sci 2009; 338:425–7. [DOI] [PubMed] [Google Scholar]
- 10. Kikuchi K, Karasawa T, Piao C, et al. Molecular confirmation of transmission route of Staphylococcus intermedius in mastoid cavity infection from dog saliva. J Infect Chemother 2004; 10:46–8. [DOI] [PubMed] [Google Scholar]
- 11. Gerstadt K, Daly JS, Mitchell M, et al. Methicillin-resistant Staphylococcus intermedius pneumonia following coronary artery bypass grafting. Clin Infect Dis 1999; 29:218–9. [DOI] [PubMed] [Google Scholar]
- 12. Atalay B, Ergin F, Cekinmez M, et al. Brain abscess caused by Staphylococcus intermedius. Acta Neurochir (Wien) 2005; 147:347–8; discussion 348. [DOI] [PubMed] [Google Scholar]
- 13. Lee J. Staphylococcus intermedius isolated from dog-bite wounds. J Infect 1994; 29:105. [DOI] [PubMed] [Google Scholar]
- 14. Choi HJ. Cervical necrotizing fasciitis resulting in acupuncture and herbal injection for submental lipoplasty. J Craniofac Surg 2014; 25:e507–9. [DOI] [PubMed] [Google Scholar]
- 15. Devriese LA, Hermans K, Baele M, Haesebrouck F. Staphylococcus pseudintermedius versus Staphylococcus intermedius. Vet Microbiol 2009; 133:206–7. [DOI] [PubMed] [Google Scholar]
- 16. Engelhardt K, Kampfl A, Spiegel M, et al. Brain abscess due to Capnocytophaga species, Actinomyces species, and Streptococcus intermedius in a patient with cyanotic congenital heart disease. Eur J Clin Microbiol Infect Dis 2002; 21:236–7. [DOI] [PubMed] [Google Scholar]
- 17. Talan DA, Goldstein EJ, Staatz D, Overturf GD. Staphylococcus intermedius: clinical presentation of a new human dog bite pathogen. Ann Emerg Med 1989; 18:410–3. [DOI] [PubMed] [Google Scholar]
- 18. Talan DA, Citron DM, Abrahamian FM, et al. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group. N Engl J Med 1999; 340:85–92. [DOI] [PubMed] [Google Scholar]
- 19. Tanner MA, Everett CL, Youvan DC. Molecular phylogenetic evidence for noninvasive zoonotic transmission of Staphylococcus intermedius from a canine pet to a human. J Clin Microbiol 2000; 38:1628–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Barnham M, Holmes B. Isolation of CDC group M-5 and Staphylococcus intermedius from infected dog bites. J Infect 1992; 25:332–4. [DOI] [PubMed] [Google Scholar]
- 21. Kelesidis T, Tsiodras S. Staphylococcus intermedius is not only a zoonotic pathogen, but may also cause skin abscesses in humans after exposure to saliva. Int J Infect Dis 2010; 14:e838–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Lainhart W, Yarbrough ML, Burnham CAD. The brief case: Staphylococcus intermedius group—look what the dog dragged in. J Clin Microbiol 2018; 56:1–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Roberson JR, Fox LK, Hancock DD, Besser TE. Evaluation of methods for differentiation of coagulase-positive staphylococci. J Clin Microbiol 1992; 30:3217–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Pottumarthy S, Schapiro JM, Prentice JL, et al. Clinical isolates of Staphylococcus intermedius masquerading as methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2004; 42:5881–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Dupuis-Gord S, Giraud S, Decullier E, et al. Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association. Clin Infect Dis 2007; 44:841–5. [DOI] [PubMed] [Google Scholar]
- 26. Press OW, Ramsey PG. Central nervous system infections associated with hereditary hemorrhagic telangiectasia. Am J Med 1984; 77:86–92. [DOI] [PubMed] [Google Scholar]
- 27. Mager JJ, Overtoom TT, Blauw H, et al. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol 2004; 15:451–6. [DOI] [PubMed] [Google Scholar]



